Internal Medicine, Hematology & Oncology · Mobile, AL
NPI
1780637579
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1700 Spring Hill Ave Ste 100
Mobile, AL, 36604
Phone (251) 435-1200
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
1,091 services
Medicare patients, 2024
312
Average age 74
Drug cost, 2024
$6.0M
1,660 prescriptions
Company payments, 2025
$1,370
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thaddeus Beeker was code 99214 (office e&m - established), 241 times for 159 patients. In total Thaddeus Beeker billed 1,091 services in 31 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 241 | 159 | $76.70 | $18K |
| 99233 Hospital E&M - Subsequent | Facility | 201 | 78 | $84.58 | $17K |
| 36415 Venipuncture Blood Collection | Office | 121 | 82 | $8.65 | $1,047 |
| 85025 Blood Count | Office | 120 | 82 | $7.61 | $913 |
| 99215 Office E&M - Established | Office | 105 | 49 | $114.81 | $12K |
| 80053 Clinical Chemistry | Office | 85 | 64 | $10.35 | $880 |
| 99222 Hospital E&M - Initial | Facility | 30 | 29 | $94.91 | $2,847 |
| 99204 Office E&M - New | Office | 23 | 23 | $100.72 | $2,317 |
| 82728 Clinical Chemistry | Office | 22 | 18 | $13.36 | $294 |
| 84466 Clinical Chemistry | Office | 19 | 17 | $12.50 | $238 |
| 83540 Clinical Chemistry | Office | 19 | 17 | $6.34 | $120 |
| 99223 Hospital E&M - Initial | Facility | 17 | 17 | $118.85 | $2,021 |
| 99213 Office E&M - Established | Office | 16 | 15 | $56.11 | $898 |
| 99442 Telephone Services | Office | 11 | 11 | $48.31 | $531 |
| 99205 Office E&M - New | Office | 11 | 11 | $144.58 | $1,590 |
By year: 2022 $94K for 1,243 services; 2023 $92K for 1,254 services; 2024 $62K for 1,091 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 121 | 82 | $8.65 | $1,047 |
| 85025 Blood Count | 120 | 82 | $7.61 | $913 |
| 80053 Clinical Chemistry | 85 | 64 | $10.35 | $880 |
| 82728 Clinical Chemistry | 22 | 18 | $13.36 | $294 |
| 83540 Clinical Chemistry | 19 | 17 | $6.34 | $120 |
| 84466 Clinical Chemistry | 19 | 17 | $12.50 | $238 |
Medicare prescription drug claims, 2024
In 2024, the drug Thaddeus Beeker prescribed most often to Medicare patients was Anastrozole, with 356 prescriptions and refills. In total Thaddeus Beeker wrote 1,660 Medicare prescriptions that cost $6.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 356 | 843 | 109 | $6,681 |
| Revlimid Lenalidomide | 103 | 103 | 12 | $2.0M |
| Letrozole Generic | 67 | 153 | 20 | $2,041 |
| Ondansetron Odt Ondansetron | 60 | 60 | 29 | $898 |
| Prochlorperazine Maleate Generic | 55 | 55 | 29 | $805 |
| Hydroxyurea Generic | 54 | 114 | 16 | $1,843 |
| Calquence Acalabrutinib Maleate | 51 | 51 | Under 11 | $742K |
| Tamoxifen Citrate Generic | 48 | 131 | 17 | $1,611 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 46 | 46 | 16 | $1,046 |
| Eliquis Apixaban | 39 | 50 | Under 11 | $29K |
| Lenalidomide Generic | 37 | 37 | Under 11 | $532K |
| Verzenio Abemaciclib | 33 | 33 | Under 11 | $491K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 32 | 32 | Under 11 | $1,403 |
| Gabapentin Generic | 30 | 40 | 11 | $254 |
| Dexamethasone Generic | 30 | 32 | Under 11 | $523 |
Brand drugs: 433 claims; generic drugs: 1,227 claims; opioid claims: 150.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thaddeus Beeker $1,370 ($1,370 in general payments such as food, travel and fees) from 25 companies. The largest payer was Novartis Pharmaceuticals Corporation with $180.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 11 | $180 |
| Janssen Biotech, Inc. JNJ | 5 | $176 |
| Merck Sharp & Dohme LLC MRK | 7 | $165 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $99.93 |
| Genzyme Corporation SNY | 1 | $97.56 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $95.41 |
| Incyte Corporation INCY | 4 | $84.17 |
| Pfizer Inc. PFE | 4 | $73.19 |
| Celgene Corporation BMY | 2 | $48.5 |
| Daiichi Sankyo Inc. 4568.T | 2 | $42.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.